Singapore, March 18 -- Avance Clinical, a leading full-service global Contract Research Organization (CRO) specialising in high-quality, agile clinical biotech research services, has announcedthe signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan-Taichung Veterans General Hospital (TCVGH);Taipei Medical University (TMU);China Medical University Hospital (CMUH); andKaohsiung Medical University Chung-Ho Memorial Hospital (KMUH).

These new partnerships mark a strategic expansion into Taiwan, reinforcing Avance Clinical's commitment to providing US biotechs with access to high-quality clinical research solutions across the Asia-Pacific region.

TCVGH is a leader in advanced CAR-T cell immunotherapy, r...